Allergenic extracts modified with glutaraldehyde (polymerized), adsorbed onto aluminum hydroxide gel for specific immunotherapy. Polymerization reduces the IgE binding of allergens to IgE while maintaining their immunogenicity, allowing a safer and quicker up-dosing.
Active substance: polymerized allergenic extracts (enviromental inhalants) formulated under medical prescription. Excipients: aluminum hydroxide, sodium chloride, phenol and water for injection.
Inmunotek standarizes its allergenic extracts in biological units (BU) following the Nordic guidelines. The biological concentration of extracts used in Alxoid is given in Therapeutic Units (TU)/mL. 10,000 TU/mL are equivalent in protein to 10,000 BU/mL of the same non-modified extract.
Rhinitis, conjunctivitis and/or asthma due to type 1 hypersensitivity (IgE-mediated) caused by available allergens.
Vial A. Silver label. Concentration 2.000 UT/mL. Volume 1.5 mL
Vial B. Blue label. Concentration 10.000 UT/mL. Volume 2.5 mL
Recommended administration guidelines
The recommended pattern(s) should be eventually adapted to the specific characteristics of the patient.